Federica Perrone

13.1k total citations · 1 hit paper
235 papers, 7.9k citations indexed

About

Federica Perrone is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Federica Perrone has authored 235 papers receiving a total of 7.9k indexed citations (citations by other indexed papers that have themselves been cited), including 130 papers in Oncology, 108 papers in Pulmonary and Respiratory Medicine and 59 papers in Surgery. Recurrent topics in Federica Perrone's work include Lung Cancer Treatments and Mutations (54 papers), Colorectal Cancer Treatments and Studies (43 papers) and Cancer Genomics and Diagnostics (27 papers). Federica Perrone is often cited by papers focused on Lung Cancer Treatments and Mutations (54 papers), Colorectal Cancer Treatments and Studies (43 papers) and Cancer Genomics and Diagnostics (27 papers). Federica Perrone collaborates with scholars based in Italy, United States and Malaysia. Federica Perrone's co-authors include Silvana Pilotti, Marco A. Pierotti, Massimo Di Maïo, Lisa Licitra, Paolo Bossi, Laura D. Locati, Pasquale Quattrone, Luigi Mariani, Elena Tamborini and Cesare Gridelli and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Federica Perrone

231 papers receiving 7.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

High-Risk Human Papillomavirus Affects Prognosis in Patients With Surgically Treated Oropharyngeal Squamous Cell Carcinoma

2006 507 citations Lisa Licitra, Federica Perrone et al. profile →

Peers

Countries citing papers authored by Federica Perrone

Since Specialization

Citations

This map shows the geographic impact of Federica Perrone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Federica Perrone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Federica Perrone more than expected).

Fields of papers citing papers by Federica Perrone

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Federica Perrone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Federica Perrone. The network helps show where Federica Perrone may publish in the future.

Co-authorship network of co-authors of Federica Perrone

This figure shows the co-authorship network connecting the top 25 collaborators of Federica Perrone. A scholar is included among the top collaborators of Federica Perrone based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Federica Perrone. Federica Perrone is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Programmed death‐ligand 1 expression and prognostic significance in bevacizumab treated ovarian cancer patients: Results from the phase IV MITO16A/MaNGO OV‐2 translational study 2025 ·Clinical and Translational Medicine ·(unknown), Vincenzo Canzonieri, Rossella De Cecio, Laura Arenare, Domenica Lorusso, Sabrina Chiara Cecere, Eliana Pivetta, Daniela Russo, Annabella Di Mauro, Grazia Artioli, Anna Spina, (unknown), Daniela Califano, Saverio Cinieri, Giosuè Scognamiglio, (unknown), Paolo Chiodini, Federica Perrone, Sandro Pignata, Gustavo Baldassarre	1
2	Active Surveillance in Patients with Extra-abdominal Desmoid-Type Fibromatosis: A Pooled Analysis of Three Prospective Observational Studies 2024 ·Clinical Cancer Research ·Chiara Colombo, (unknown), Axel Le Cesne, Francesco Barretta, Jean‐Yves Blay, Dirk J. Grünhagen, Nicolas Penel, (unknown), Marco Fiore, Elena Palassini, Giovanni Grignani, Francesco Tolomeo, Paola Collini, Alessandra Merlini, Federica Perrone, Silvia Stacchiotti, Cornelis Verhoef, (unknown), Sylvie Bonvalot, (unknown), Alessandro Gronchi	2
3	1355P Evaluation of the role of variant allele frequency in EGFR mutated non-small cell lung cancer treated with first line osimertinib 2023 ·Annals of Oncology ·(unknown), Daniele Lorenzini, Mario Occhipinti, Sara Manglaviti, (unknown), Laura Mazzeo, Luca Agnelli, Rita Leporati, (unknown), Alberto Giovanni Leone, (unknown), Arsela Prelaj, Giuseppe Lo Russo, (unknown), Elena Tamborini, Federica Perrone, Monica Ganzinelli, Giancarlo Pruneri, Filippo de Braud, Claudia Proto	1
4	Position paper of the Italian association of medical oncology on health disparities among transgender and gender-diverse people: the Assisi recommendations 2023 ·EClinicalMedicine ·Alberto Giovanni Leone, Raffaella Casolino, Dario Trapani, Rosalba Miceli, (unknown), Federica Morano, Nicla La Verde, Davide Dalu, Rossana Berardi, Silvia Marsoni, Matteo Lambertini, (unknown), (unknown), Manlio Converti, Massimo Di Maïo, Giordano Beretta, Federica Perrone, Filippo Pietrantonio, Saverio Cinieri	7
5	The Revolution of Immunotherapy in Gynecological Cancers: The Lazarus Effect in Endometrial Cancer 2023 ·Journal of Clinical Medicine ·Monika Ducceschi, (unknown), Marta Bini, Salvatore Lopez, Elena Conca, Elena Tamborini, Federica Perrone, G Stella, (unknown), (unknown), Grazia Artioli, Valeria Maffeis, (unknown), Francesco Raspagliesi, (unknown)	1
6	A2AR Expression and Immunosuppressive Environment Independent of KRAS and GNAS Mutations in Pseudomyxoma Peritonei 2023 ·Biomedicines ·Shigeki Kusamura, Adele Busico, Elena Conca, Iolanda Capone, Luca Agnelli, Daniele Lorenzini, Silvia Brich, (unknown), Chiara Costanza Volpi, (unknown), (unknown), (unknown), Annunziata Gloghini, Dario Baratti, Marcello Guagliò, Massimo Milione, Marcello Deraco, Federica Perrone	5
7	Targeted RNA-sequencing analysis for fusion transcripts detection in tumor diagnostics: assessment of bioinformatic tools reliability in FFPE samples 2022 ·SHILAP Revista de lepidopterología ·Iolanda Capone, Fabio Bozzi, Gian Paolo Dagrada, Paolo Verderio, Elena Conca, Adele Busico, M. Testi, Valentina Monti, Matteo Duca, Claudia Proto, Silvia Damian, (unknown), Federica Perrone, Elena Tamborini, (unknown), Paola Collini, Daniele Lorenzini, Andrea Vingiani, Luca Agnelli, Giancarlo Pruneri	3
8	Rationale and Study Design of the PARERE Trial: Randomized phase II Study of Panitumumab Re-Treatment Followed by Regorafenib Versus the Reverse Sequence in RAS and BRAF Wild-Type Chemo-Refractory Metastatic Colorectal Cancer Patients 2021 ·Clinical Colorectal Cancer ·Roberto Moretto, Daniele Rossini, Iolanda Capone, Alessandra Boccaccino, Federica Perrone, Elena Tamborini, Gianluca Masi, Carlotta Antoniotti, Federica Marmorino, Veronica Conca, Beatrice Borelli, Angelo Martignetti, Irene Pecora, Francesca Simionato, Samanta Cupini, Margherita Ambrosini, Paolo Manca, Filippo Pietrantonio, Alfredo Falcone, Chiara Cremolini	12
9	Improved Prognostic Prediction in Never-Smoker Lung Cancer Patients by Integration of a Systemic Inflammation Marker with Tumor Immune Contexture Analysis 2020 ·Cancers ·Massimo Milione, Mattia Boeri, Anna Cantarutti, Giovanni Centonze, Adele Busico, Paola Suatoni, (unknown), Laura Cattaneo, Elena Tamborini, Federica Perrone, Alessandro Mangogna, Giovanni Corrao, Giancarlo Pruneri, Gabriella Sozzi, Andrea Anichini, Ugo Pastorino	1
10	Cancer Associated Fibroblasts and Senescent Thyroid Cells in the Invasive Front of Thyroid Carcinoma 2020 ·Cancers ·Emanuela Minna, Silvia Brich, Katia Todoerti, Silvana Pilotti, Paola Collini, (unknown), Paola Romeo, Loris De Cecco, Matteo Dugo, Federica Perrone, Adele Busico, Andrea Vingiani, Ilaria Bersani, Andrea Anichini, Roberta Mortarini, Antonino Neri, Giancarlo Pruneri, Angela Greco, Maria Grazia Borrello	40
11	Tumor Biomarkers for the Prediction of Distant Metastasis in Head and Neck Squamous Cell Carcinoma 2020 ·Cancers ·Salvatore Alfieri, (unknown), Francesca Platini, (unknown), Federica Perrone, Donata Galbiati, (unknown), Roberta Depenni, Andrea Vingiani, Pasquale Quattrone, Edoardo Marchesi, (unknown), (unknown), Elisa Mancinelli, Ester Orlandi, Sara Marceglia, Laura D. Locati, Lisa Licitra, Paolo Bossi, Loris De Cecco	12
12	A functional gene expression analysis in epithelial sinonasal cancer: Biology and clinical relevance behind three histological subtypes 2019 ·Oral Oncology ·Loris De Cecco, (unknown), Carla Facco, Roberta Granata, Ester Orlandi, C. Fallai, Lisa Licitra, Edoardo Marchesi, Federica Perrone, Silvana Pilotti, Pasquale Quattrone, Cesare Piazza, Fausto Sessa, Mario Turri–Zanoni, Paolo Battaglia, Paolo Castelnuovo, Paolo Antognoni, Silvana Canevari, Paolo Bossi	10
13	MET-Driven Resistance to Dual EGFR and BRAF Blockade May Be Overcome by Switching from EGFR to MET Inhibition in BRAF -Mutated Colorectal Cancer 2016 ·Cancer Discovery ·Filippo Pietrantonio, Daniele Oddo, Annunziata Gloghini, Emanuele Valtorta, Rosa Berenato, Ludovic Barault, Marta Caporale, Adele Busico, Federica Morano, Ambra V. Gualeni, Alessandra Alessi, Giulia Siravegna, Federica Perrone, Maria Di Bartolomeo, Alberto Bardelli, Filippo de Braud, Federica Di Nicolantonio	78
14	Functional Genomics Uncover the Biology behind the Responsiveness of Head and Neck Squamous Cell Cancer Patients to Cetuximab 2016 ·Clinical Cancer Research ·Paolo Bossi, Cristiana Bergamini, Marco Siano, Maria Cossu Rocca, (unknown), (unknown), (unknown), Edoardo Marchesi, Barbara Cortelazzi, Federica Perrone, Silvana Pilotti, Laura D. Locati, Lisa Licitra, Silvana Canevari, Loris De Cecco	53
15	BRAF mutation analysis is a valid tool to implement in Lynch syndrome diagnosis in patients classified according to the Bethesda guidelines. 2014 ·PubMed ·Francesca Molinari, Stefano Signoroni, Andrea Lampis, Cláudia Bertan, Federica Perrone, Paola Sala, P Mondini, Stefano Crippa, Lucio Bertario, Milo Frattini	6
16	CTNNB1 45F mutation is a molecular prognosticator of increased postoperative primary desmoid tumor recurrence 2013 ·Cancer ·Chiara Colombo, Rosalba Miceli, Alexander J. Lazar, Federica Perrone, Raphael E. Pollock, Axel Le Cesne, Henk H. Hartgrink, Anne‐Marie Cleton-Jansen, Julien Dômont, Judith V.M.G. Bovée, Sylvie Bonvalot, Dina Lev, Alessandro Gronchi	132
17	miRNA Profiling in Colorectal Cancer Highlights miR-1 Involvement in MET-Dependent Proliferation 2012 ·Molecular Cancer Research ·James F. Reid, (unknown), Eugenio Zoni, Andrea Lampis, Sara Pizzamiglio, Cláudia Bertan, Susanna Zanutto, Federica Perrone, Tiziana Camerini, Gianfrancesco Gallino, Paolo Verderio, Ermanno Leo, Silvana Pilotti, Manuela Gariboldi, Marco A. Pierotti	114
18	Recent issues in first-line treatment of advanced non-small-cell lung cancer: Results of an International Expert Panel Meeting of the Italian Association of Thoracic Oncology 2009 ·Lung Cancer ·Cesare Gridelli, Andrea Ardizzoni, Jean‐Yves Douillard, Nasser H. Hanna, Christian Manegold, Federica Perrone, Robert Pirker, Rafael Rosell, Frances A. Shepherd, Luigi De Petris, Massimo Di Maïo, Filippo de Marinis	57
19	Clear cell adenocarcinoma of the colon is a unique morphological variant of intestinal carcinoma: Case report with molecular analysis 2008 ·World Journal of Gastroenterology ·Marta Barisella, Andrea Lampis, Federica Perrone, Antonino Carbone	14
20	Hepatic Resection and Percutaneous Ethanol Injection as Treatments of Small Hepatocellular Carcinoma 2003 ·Journal of Clinical Gastroenterology ·Bruno Daniele, Ilario de Sio, Francesco Izzo, (unknown), A Andreana, Roberto Mazzanti, (unknown), Paolo Vallone, Francesco Fiore, G.B. Gaeta, Federica Perrone, Sandro Pignata, Ciro Gallo	44

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact